Cyclin D1 is essential for neoplastic transformation induced by both E6/E7 and E6/E7/ErbB-2 cooperation in normal cells

Oncogene

Volumn 23, Issue 30, 2004, Pages 5252-5256

  Al Moustafa, Ala Eddin ^a,g   Foulkes, William D ^a,b   Wong, Annick ^a   Jallal, Houda ^a   Batist, Gerald ^a   Yu, Qunyan ^c,d   Herlyn, Meenhard ^e,f   Sicinski, Piotr ^c,d   Alaoui Jamali, Moulay A ^a  

^a MCGILL UNIVERSITY   (Canada)

^b MCGILL UNIVERSITY HEALTH CENTRE   (Canada)

^c DANA FARBER CANCER INSTITUTE   (United States)

^d HARVARD MEDICAL SCHOOL   (United States)

^e WISTAR INSTITUTE   (United States)

^f FOX CHASE CANCER CENTER   (United States)

^g MCGILL UNIVERSITY   (Canada)

Author keywords

Cell transformation; Cyclin D1; E6 E7 of HPV; ErbB 2

Indexed keywords

AGAR; ANTINEOPLASTIC AGENT; ANTISENSE CYCLIN D1; CYCLIN D1; EPIDERMAL GROWTH FACTOR RECEPTOR 2; PROTEIN E6; PROTEIN E7; UNCLASSIFIED DRUG; ONCOPROTEIN;

ANIMAL CELL; ARTICLE; CARCINOGENESIS; CELL TRANSFORMATION; COLONY FORMATION; CONTROLLED STUDY; EMBRYO; FIBROBLAST; HUMAN; HUMAN CELL; KNOCKOUT GENE; MALIGNANT TRANSFORMATION; MOUSE; NONHUMAN; NUDE MOUSE; PRIORITY JOURNAL; TUMOR VOLUME; WILD TYPE; ANIMAL; CANCER TRANSPLANTATION; CELL LINE; CLONOGENIC ASSAY; COMPARATIVE STUDY; CYTOLOGY; EPITHELIUM CELL; GENE EXPRESSION REGULATION; GENETICS; IMMUNOHISTOCHEMISTRY; METABOLISM; MOUTH MUCOSA; PAPILLOMA VIRUS; PATHOLOGY; WESTERN BLOTTING;

ANIMALIA; MUS MUSCULUS; PAPILLOMAVIRUS;

ANIMALS; BLOTTING, WESTERN; CELL LINE, TRANSFORMED; CELL TRANSFORMATION, NEOPLASTIC; COLONY-FORMING UNITS ASSAY; CYCLIN D1; EMBRYO; EPITHELIAL CELLS; FIBROBLASTS; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; IMMUNOHISTOCHEMISTRY; MICE; MICE, NUDE; MOUTH MUCOSA; NEOPLASM TRANSPLANTATION; ONCOGENE PROTEINS, VIRAL; PAPILLOMAVIRIDAE; RECEPTOR, ERBB-2;

EID: 3142701640     PISSN: 09509232     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.onc.1207679     Document Type: Article

References (28)

1. Al Moustafa A-E, Foulkes W, Benlimame N, Wong A, Batist G, Yen L, Bergeron J, Batist G, Alpert L and Alaoui-Jamali M. (2004). Oncogene, 23, 350-358.
2. Almadori G, Galli J, Cadoni G, Bussu F and Maurizi M. (2002). Head Neck, 24, 597-604.
3. Carraresi L, Tripodi SA, Mulder LC, Bertini S, Nuti S, Schuerfeld K, Cintorino M, Bensi G, Rossini M and Mora M. (2001). Oncogene, 20, 8148-8153.
4. Cheung TH, Yu MM, Lo KW, Yim SF, Chung TK and Wong YF. (2001). Cancer Lett., 166, 199-206.
5. Clifford GM, Smith JS, Plummer M, Munoz N and Franceschi S. (2003). Br. J. Cancer, 88, 63-73.
6. Decker T, Schneller F, Hipp S, Miething C, Jahn T, Duyster J and Peschel C. (2002). Leukemia, 16, 327-334.
7. Eckert RL, Crish JF, Balasubramanian S and Rorke EA. (2000). Int. J. Oncol., 16, 853-870.
8. Gasco M and Crook T. (2003). Oral Oncol., 39, 222-231.
9. Gillison ML, Koch WM, Capone RB, Spafford M, Westra WH, Wu L, Zahurak ML, Daniel RW, Viglione M, Symer DE, Shah KV and Sidransky D. (2000). J. Natl. Cancer Inst., 92, 709-720.
10. Ibrahim SO, Lillehaug JR, Johannessen AC, Liavaag PG, Nilsen R and Vasstrand EN. (1999). Oral Oncol., 35, 302-313.
11. Ke LD, Adler-Storthz K, Mitchell MF, Clayman GL and Chen Z. (1999). Oral Oncol., 35, 415-420.
12. Lee JS, Kim HS, Jung JJ, Lee MC and Park CS. (2002). Gynecol. Oncol., 85, 469-475.
13. Lin SY, Xia W, Wang JC, Kwong KY, Spohn B, Wen Y, Pestell RG and Hung MC. (2000). Proc. Natl. Acad. Sci. USA, 97, 4262-4266.
14. Liu SC, Bassi DE, Zhang SY, Holoran D, Conti CJ and Klein-Szanto AJ. (2002). Mol. Carcinogen., 34, 131-139.
15. Moreno V, Bosch FX, Munoz N, Meijer CJ, Shah KV, Walboomers JM, Herrero R and Franceschi S. (2002). Lancet, 359, 1085-1092.
16. Niv A, Sion-Vardi N, Gatot A, Nash M and Fliss DM. (2000). J. Laryngol. Otol., 114, 41-46.
17. Robles AI, Rodriguez-Puebla ML, Glick AB, Trempus C, Hansen L, Sicinski P, Tennant RW, Weinberg RA, Yuspa SH and Conti CJ. (1998). Genes Dev., 12, 2469-2474.
18. Rousseau A, Lim MS, Lin Z and Jordan RC. (2001). Oral Oncol., 37, 268-275.
19. Sauter ER, Herlyn M, Liu SC, Litwin S and Ridge JA. (2000). Clin. Cancer Res., 6, 654-660.
20. Sauter ER, Nesbit M, Litwin S, Klein-Szanto AJ, Cheffetz S and Herlyn M. (1999). Cancer Res., 59, 4876-4881.
21. Sauter ER, Takemoto R, Litwin S and Herlyn M. (2002a). Cancer Gene Ther., 9, 807-812.
22. Sauter ER, Yeo UC, von Stemm A, Zhu W, Litwin S, Tichansky DS, Pistritto G, Nesbit M, Pinkel D, Herlyn M and Bastian BC. (2002b). Cancer Res., 62, 3200-3206.
23. Sherr CJ and Roberts JM, (1999). Genes Dev., 13, 1501-1512.
24. Shtutman M, Zhurinsky J, Simcha I, Albanese C, D'Amico M, Pestell R and Ben-Ze'ev A. (1999). Proc. Natl. Acad. Sci. USA, 96, 5522-5527.
25. Sicinski P, Donaher JL, Parker SB, Li T, Fazeli A, Gardner H, Haslam SZ, Bronson RT, Elledge SJ and Weinberg RA. (1995). Cell, 82, 621-630.
26. Wilkman TS, Hietanen JH, Malmstrom MJ and Konttinen YT. (1998). Int. J. Oral Maxillofac. Surg., 27, 209-212.
27. Xia W, Lau YK, Zhang HZ, Liu AR, Li L, Kiyokawa N, Clayman GL, Katz RL and Hung MC. (1997). Clin. Cancer Res., 3, 3-9.
28. Yu Q, Geng Y and Sicinski P. (2001). Nature, 411, 1017-1021.